EUVIMEDEUVIMED entdecken
Open Access

Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles

Mohamed Ghalwash, Vibha Anand iD, Kenney Ng iD, Jessica L Dunne, Olivia Lou, Markus Lundgren, William A Hagopian, Marian Rewers, Anette-G Ziegler iD, Riitta Veijola iD, T1DI Study Group

Diabetes Care · 2024

DOI: 10.2337/dc24-0198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, 2024. Verfasst von Mohamed Ghalwash und 10 weiteren Autor:innen. Beteiligte Einrichtung: T.J. Watson Research Center, IBM, Yorktown Heights, NY. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Autoantibodies. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Breakthrough T1D, JDRF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To characterize distinct islet autoantibody profiles preceding stage 3 type 1 diabetes RESEARCH DESIGN AND METHODS The T1DI (Type 1 Diabetes Intelligence) study combined data from 1,845 genetically susceptible prospectively observed children who were positive for at least one islet autoantibody: insulin autoantibody (IAA), GAD antibody (GADA), or islet antigen 2 antibody (IA-2A). Using a novel similarity algorithm that considers an individual’s temporal autoantibody profile, age at autoantibody appearance, and variation in the positivity of autoantibody types, we performed an unsupervised hierarchical clustering analysis. Progression rates to diabetes were analyzed via survival analysis. RESULTS We identified five main clusters of individuals with distinct autoantibody profiles characterized by seroconversion age and sequence of appearance of the three autoantibodies. The highest 5-year risk from first positive autoantibody to type 1 diabetes (69.9%; 95% CI 60.0–79.2) was observed in children who first developed IAA in early life (median age 1.6 years) followed by GADA (1.9 years) and then IA-2A (2.1 years). Their 10-year risk was 89.9% (95% CI 81.9–95.4). A high 5-year risk was also found in children with persistent IAA and GADA (39.1%) and children with persistent GADA and IA-2A (30.9%). A lower 5-year risk (10.5%) was observed in children with a late appearance of persistent GADA (6.1 years). The lowest 5-year diabetes risk (1.6%) was associated with positivity for a single, often reverting, autoantibody. CONCLUSIONS The novel clustering algorithm identified children with distinct islet autoantibody profiles and progression rates to diabetes. These results are useful for prediction, selection of individuals for prevention trials, and studies investigating various pathways to type 1 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1AutoantibodiesHumansChildFemaleMaleChild, PreschoolAdolescentInfantPhenotypeInsulin Antibodies

Substanzen

AutoantibodiesInsulin Antibodies

Autor:innen und Institutionen

  • T.J. Watson Research Center, IBM, Yorktown Heights, NY.
  • Faculty of Science, Ain Shams University, Cairo, Egypt.
  • T.J. Watson Research Center, IBM, Cambridge, MA.
  • JDRF, New York, NY.
  • Department of Clinical Sciences, Lund University/Clinical Research Centre, Skåne University Hospital, Malmö, Sweden.
  • Pacific Northwest Research Institute, Seattle, WA.

ORCID-Profile: Vibha Anand, Kenney Ng, Anette-G Ziegler, Riitta Veijola

Förderung

  • NIDDK NIH HHS
  • Breakthrough T1D
  • JDRF

Zitieren

APA

Ghalwash, M., Anand, V., Ng, K., Dunne, J. L., Lou, O., Lundgren, M., Hagopian, W. A., Rewers, M., Ziegler, A. G., Veijola, R., & T1DI Study Group (2024). Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles. Diabetes Care. https://doi.org/10.2337/dc24-0198

Vancouver

Ghalwash M, Anand V, Ng K, Dunne JL, Lou O, Lundgren M, et al. Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles. Diabetes Care. 2024. doi:10.2337/dc24-0198

BibTeX
@article{Ghalwash2024,
  author = {Ghalwash, Mohamed and Anand, Vibha and Ng, Kenney and Dunne, Jessica L and Lou, Olivia and Lundgren, Markus and Hagopian, William A and Rewers, Marian and Ziegler, Anette-G and Veijola, Riitta and T1DI Study Group, T1DI Study Group},
  title = {Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles},
  journal = {Diabetes Care},
  year = {2024},
  doi = {10.2337/dc24-0198}
}
Kostenlos starten →